[Abstract] Objective: To investigate YANGXUEQINGNAOKELI for treatment of patients with depression after cerebral infarction. Method: The June 2016 ~ cerebral infarction depression 100 patients in June 2019 into our hospital divided into two groups, a control group treated according Paluoxiting randomly; group was observed in the control group plus basis treated Yangxueqingnao were compared Princeton Hamilton depression scale (the HAMD), Hamilton anxiety scale (HAMA), stroke neurological deficit score scale (the NIHSS) score and cortisol, norepinephrine (NE) , dopamine (DA) and serotonin (5-HT) levels, and adverse reactions. Results: After treatment, both groups NIHSS, HAMD, HAMA score, decreased cortisol levels than before treatment, observation group was significantly lower than control group (P <0.05), two groups of 5-HT, DA and NE were increased significantly, observation group was significantly higher (P <0.05); groups rate of adverse reactions was no significant difference (P> 0.05). Conclusion: YANGXUEQINGNAOKELI joint Paluoxiting after treatment of cerebral infarction depression effect is remarkable, without increasing adverse effects.
正在翻译中..